BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19760774)

  • 1. Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association.
    McDonald S; Wilson DB; Pumbo E; Kulkarni S; Mason PJ; Else T; Bessler M; Ferkol T; Shenoy S
    Pediatr Blood Cancer; 2010 Jan; 54(1):154-7. PubMed ID: 19760774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features of dyskeratosis congenita and IMAGe association.
    Wilson DB; Bessler M; Ferkol TW; Shenoy S; Amano N; Ishii T; Shima H; Narumi S
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28834235
    [No Abstract]   [Full Text] [Related]  

  • 3. Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1.
    Kocak H; Ballew BJ; Bisht K; Eggebeen R; Hicks BD; Suman S; O'Neil A; Giri N; ; ; Maillard I; Alter BP; Keegan CE; Nandakumar J; Savage SA
    Genes Dev; 2014 Oct; 28(19):2090-102. PubMed ID: 25233904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita.
    Bessler M; Wilson DB; Mason PJ
    FEBS Lett; 2010 Sep; 584(17):3831-8. PubMed ID: 20493861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase.
    Yang D; He Q; Kim H; Ma W; Songyang Z
    J Biol Chem; 2011 Jul; 286(26):23022-30. PubMed ID: 21536674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered telomere degradation models dyskeratosis congenita.
    Hockemeyer D; Palm W; Wang RC; Couto SS; de Lange T
    Genes Dev; 2008 Jul; 22(13):1773-85. PubMed ID: 18550783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
    Gramatges MM; Bertuch AA
    Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of dyskeratosis congenita.
    Mason PJ; Bessler M
    Cancer Genet; 2011 Dec; 204(12):635-45. PubMed ID: 22285015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice.
    Frescas D; de Lange T
    Genes Dev; 2014 Jan; 28(2):153-66. PubMed ID: 24449270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2.
    Vulliamy T; Beswick R; Kirwan MJ; Hossain U; Walne AJ; Dokal I
    Clin Genet; 2012 Jan; 81(1):76-81. PubMed ID: 21199492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex.
    Sarper N; Zengin E; Kılıç SÇ
    Pediatr Blood Cancer; 2010 Dec; 55(6):1185-6. PubMed ID: 20979174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita.
    Kirschner M; Vieri M; Kricheldorf K; Ferreira MSV; Wlodarski MW; Schwarz M; Balabanov S; Rolles B; Isfort S; Koschmieder S; Höchsmann B; Panse J; Brümmendorf TH; Beier F
    Br J Haematol; 2021 May; 193(3):669-673. PubMed ID: 32744739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional consequences of a disease mutation in the telomere protein TPP1.
    Bisht K; Smith EM; Tesmer VM; Nandakumar J
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13021-13026. PubMed ID: 27807141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POT of gold: modeling dyskeratosis congenita in the mouse.
    Autexier C
    Genes Dev; 2008 Jul; 22(13):1731-6. PubMed ID: 18593874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic TERT variant leads to Hoyeraal-Hreidarsson syndrome with additional dyskeratosis congenita findings.
    Çepni E; Satkın NB; Moheb LA; Rocha ME; Kayserili H
    Am J Med Genet A; 2022 Apr; 188(4):1226-1232. PubMed ID: 34890115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase insufficiency induced telomere erosion accumulation in successive generations in dyskeratosis congenita family.
    He C; Jing S; Dai C; Tu C; Tan Z; Du J; Lu GX; Lin G; Zeng S
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00709. PubMed ID: 31119896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
    Mason PJ; Wilson DB; Bessler M
    Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous remission of myelodysplastic syndrome with monosomy 7 in a young boy.
    Parker TM; Klaassen RJ; Johnston DL
    Cancer Genet Cytogenet; 2008 Apr; 182(2):122-5. PubMed ID: 18406874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
    Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
    Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.